Relationship between non-specific prescription pill adherence and Ischemic stroke outcomes

Cerebrovascular Diseases

Volumn 29, Issue 2, 2010, Pages 146-153

  Ovbiagele, Bruce ^a   Campbell, Stephen ^b   Faiz, Ali ^b   Chambless, Lloyd E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IL   (United States)

Author keywords

Adherence; Compliance; Outcomes; Prescription; Stroke, ischemic

Indexed keywords

COBALAMIN; FOLIC ACID; PYRIDOXINE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEATH; DOUBLE BLIND PROCEDURE; ETHNICITY; FEMALE; HEALTH BEHAVIOR; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PILL; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SMOKING; STROKE PATIENT;

BRAIN ISCHEMIA; CANADA; DOUBLE-BLIND METHOD; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PRESCRIPTION DRUGS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; STROKE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VITAMINS;

EID: 70849095713     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000262311     Document Type: Article

References (21)

1. Sacco RL, Adams R, Albers G, et al: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577-617. (Pubitemid 43732031)
2. Holloway RG, Benesch C, Rush SR: Stroke prevention: narrowing the evidence-practice gap. Neurology 2000; 54: 1899-1906
3. Reeves MJ, Arora S, Broderick JP, et al: Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005; 36: 1232-1240.
4. Ovbiagele B, Saver JL: Ensuring management of vascular risk factors after stroke. Rev Neurol Dis 2006; 3: 93-100.
5. Simpson SH, Eurich DT, Majumdar SR, et al: A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
6. Horwitz RI, Viscoli CM, Berkman L, et al: Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542-545.
7. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980; 303: 1038-1041.
8. Granger BB, Swedberg K, Ekman I, et al: Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005; 366: 2005-2011.
9. Toole J, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565-575.
10. Eldred LJ, Wu AW, Chaisson RE, Moore RD: Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 117-1125.
11. Lopez-Suarez A, Fernandez-Gutierrez del Alam C, Perez-Guzman E, Giron-Gonalez JA: Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS 1998; 12: 685-686.
12. Rodriguez-Rosado R, Jimenez-Nacher I, Soriano V, Anton P, Gonzalez-Lahoz J: Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS 1998; 12: 1112-1113.
13. Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA: Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr 2002; 30: 105-110.
14. Knobel H, Urbina O, Gonzalez A, et al: Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow- up. HIV Med 2009; 10: 364-369.
15. Paterson DL, Swindells S, Mohr J, et al: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
16. Czajkowski S, Chesney M, Smith A: Adherence and the Placebo Effect; in Shumaker S, Schron E, Ockene J (eds): The Handbook of Health Behavior Change. New York, Springer, 1990 pp 515-534.
17. Irvine J, Baker B, Smith J, et al: Poor Adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Psychosom Med 1999; 61: 566-575.
18. Carney R, Freedland K, Eisen S, Rich M, Jaffe A: Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995; 14: 88-90.
19. Bastone E, Kerns R: Effects of self-efficacy and perceived social support on recovery-related behaviors after coronary artery bypass surgery. Ann Behav Med 1995; 17: 324-330.
20. Doherty W, Schrott H, Metcalf L, Iasiello- Vailas L: Effect of spouse support and health beliefs on medication adherence. J Fam Pract 1983; 17: 837-841.
21. Logan A, Irvine M: Compliance, labelling, and hypertension; in Swales J (ed): Textbook of Hypertension. Oxford, Blackwell Scientific, 1994, pp 1267-1282.